Xiujun Cai
Impact in
- Hepatology top 0.5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Cancer Research top 1%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
- Hepatology 52
- Hepatocellular Carcinoma Treatment and Prognosis 43
-
- MicroRNA in disease regulation 18
- Cancer-related molecular mechanisms research 10
- Co-authors
- Xiao Huan Liang (37 shared papers)Yuelong Liang (28 shared papers)Mingyu Chen (39 shared papers)Hong Yu (28 shared papers)Junjie Xu (17 shared papers)Hui Min Lin (22 shared papers)Sarun Juengpanich (24 shared papers)Yifan Wang (36 shared papers)
- Journals
- Nature Communications (8 papers)Liver Cancer (7 papers)Oncotarget (6 papers)Frontiers in Oncology (6 papers)Journal of Laparoendoscopic & Advanced Surgical Techniques (5 papers)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Xiujun Cai
242 papers receiving 9.0k citations
Xiujun Cai's Hit Papers
Peers
Comparison fields: 5 of 150
- Hepatology 1.7k
- Cancer Research 1.8k
- Oncology 1.2k
- Molecular Biology 3.2k
- Pulmonary and Respiratory Medicine 1.1k
Countries citing papers authored by Xiujun Cai
This map shows the geographic impact of Xiujun Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiujun Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiujun Cai more than expected).
Fields of papers citing papers by Xiujun Cai
This network shows the impact of papers produced by Xiujun Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiujun Cai. The network helps show where Xiujun Cai may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiujun Cai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 252 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition) Hit paper breakdown → | 2020 | 618 |
| 2 | Targeting mutant p53 for cancer therapy: direct and indirect strategies Hit paper breakdown → | 2021 | 386 |
| 3 | CircRNA-SORE mediates sorafenib resistance in hepatocellular carcinoma by stabilizing YBX1 Hit paper breakdown → | 2020 | 355 |
| 4 | Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition) Hit paper breakdown → | 2023 | 305 |
| 5 | 2020 | 240 | |
| 6 | 2020 | 229 | |
| 7 | 2015 | 215 | |
| 8 | 2021 | 203 | |
| 9 | 2020 | 192 | |
| 10 | 2020 | 187 | |
| 11 | 2020 | 163 | |
| 12 | Chinese expert consensus on conversion therapy for hepatocellular carcinoma (2021 edition) Hit paper breakdown → | 2022 | 147 |
| 13 | 2020 | 139 | |
| 14 | 2017 | 139 | |
| 15 | 2014 | 134 | |
| 16 | 2016 | 131 | |
| 17 | 2018 | 128 | |
| 18 | 2015 | 110 | |
| 19 | 2021 | 107 | |
| 20 | 2021 | 103 |
About Xiujun Cai
Xiujun Cai is a scholar working on Hepatology, Cancer Research, Oncology, Surgery and Molecular Biology, having authored 252 papers that have together received 9.1k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (43 papers), Nanoplatforms for cancer theranostics (21 papers), MicroRNA in disease regulation (18 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (17 papers), Cancer Mechanisms and Therapy (13 papers), Circular RNAs in diseases (13 papers), RNA modifications and cancer (12 papers) and Cancer-related molecular mechanisms research (10 papers). The work is most often cited by research in Hepatology (1.7k citations), Cancer Research (1.8k citations), Oncology (1.2k citations), Molecular Biology (3.2k citations) and Pulmonary and Respiratory Medicine (1.1k citations). Xiujun Cai has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Xiao Huan Liang, Yuelong Liang, Mingyu Chen, Hong Yu, Junjie Xu, Hui Min Lin, Sarun Juengpanich, Yifan Wang, Renan Jin and Jiasheng Cao. Their work appears in journals such as Nature Communications, Liver Cancer, Oncotarget, Frontiers in Oncology and Journal of Laparoendoscopic & Advanced Surgical Techniques.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.